Recurrent pancreatic acinar cell carcinoma following a 7-year disease-free interval: A case report and literature review

Introduction and importance: Pancreatic acinar cell carcinoma (PACC) is a rare malignant pancreatic tumor, accounting for only 1% of all pancreatic neoplasms. It has distinctive clinical, radiological, and histological features. Case presentation: Here, we report a case of PACC diagnosed 7 years after surgical treatment for pancreatic ductal adenocarcinoma (PDAC). The recurrence was suspected during routine follow-up via abdominal computed tomography scan, which showed a local mass without biliary ducts dilation, vascular involvement, or any specific radiological signs. However, clinical examination and laboratory workup, including tumor markers (CA 19-9 and carcinoembryonic antigen), were normal. By comparing samples obtained via endoscopic ultrasound fine-needle aspiration of the pancreatic mass to the histopathological findings of the prior duodenopancreatectomy, a diagnosis of local recurrence of previously misdiagnosed PACC was established. Clinical discussion: PACC is a rare pancreatic epithelial malignancy (1%), for which radical surgical resection remains the treatment of choice. However, it is usually diagnosed at an advanced stage (with metastasis). The most common differential diagnoses include pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, solid pseudopapillary neoplasms, and pancreatoblastoma in the pediatric population. Histopathological examination combined with immunohistochemical staining remains the cornerstone for establishing the diagnosis. In our case, ultrasound-guided fine needle aspiration of the pancreatic mass, compared to the previous duodenopancreatectomy, led to the diagnosis of a local recurrence of a previously misdiagnosed initially as PDAC, with the longest survival (84 months) ever described in the literature. Conclusions: Due to its rarity, PACC remains a diagnostic challenge. It has a better prognosis than PDAC; radical resection is recommended.

Authors

Institutions

Publication Details

Journal
International Journal of Surgery Case Reports
Published
2026-03-12
DOI
https://doi.org/10.1097/rc9.0000000000000113
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrent pancreatic acinar cell carcinoma following a 7-year disease-free interval: A case report and literature review

Abdelkrim Zazour, Anass Haloui, Zahi Ismaili, Imane Kamaoui et al.
International Journal of Surgery Case Reports
Pancreatic and Hepatic Oncology Research
article

Recurrent pancreatic acinar cell carcinoma following a 7-year disease-free interval: A case report and literature review

Abdelkrim Zazour, Anass Haloui, Zahi Ismaili, Imane Kamaoui, Ghizlane Kharrasse, Chorouq Mehdaoui
article en

Abstract

Introduction and importance: Pancreatic acinar cell carcinoma (PACC) is a rare malignant pancreatic tumor, accounting for only 1% of all pancreatic neoplasms. It has distinctive clinical, radiological, and histological features. Case presentation: Here, we report a case of PACC diagnosed 7 years after surgical treatment for pancreatic ductal adenocarcinoma (PDAC). The recurrence was suspected during routine follow-up via abdominal computed tomography scan, which showed a local mass without biliary ducts dilation, vascular involvement, or any specific radiological signs. However, clinical examination and laboratory workup, including tumor markers (CA 19-9 and carcinoembryonic antigen), were normal. By comparing samples obtained via endoscopic ultrasound fine-needle aspiration of the pancreatic mass to the histopathological findings of the prior duodenopancreatectomy, a diagnosis of local recurrence of previously misdiagnosed PACC was established. Clinical discussion: PACC is a rare pancreatic epithelial malignancy (1%), for which radical surgical resection remains the treatment of choice. However, it is usually diagnosed at an advanced stage (with metastasis). The most common differential diagnoses include pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, solid pseudopapillary neoplasms, and pancreatoblastoma in the pediatric population. Histopathological examination combined with immunohistochemical staining remains the cornerstone for establishing the diagnosis. In our case, ultrasound-guided fine needle aspiration of the pancreatic mass, compared to the previous duodenopancreatectomy, led to the diagnosis of a local recurrence of a previously misdiagnosed initially as PDAC, with the longest survival (84 months) ever described in the literature. Conclusions: Due to its rarity, PACC remains a diagnostic challenge. It has a better prognosis than PDAC; radical resection is recommended.

International Journal of Surgery Case Reports
Mohamed I University (MA)
Good health and well-being
Openalex Percentile: Top 24%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.